Scholarlink

<p>Epigenetic therapies represent a&#xa0;novel and promising approach to treating a&#xa0;wide range of diseases, particularly cancer. By targeting and reversing the epigenetic changes, these therapies can precisely modulate gene expression to interfere with tumor growth and progression. Using EZH2 (enhancer of zeste homolog&#xa0;2) inhibitors as a&#xa0;case study, we delve into recent advancements in the field of epigenetic therapy and discuss strategies to fully harness the potential of epigenetic therapeutics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Epigenetische Therapien in der Krebsbehandlung: Chancen und Herausforderungen

  • 期刊论文

  • 发表日期：

    2025年1月6日

查看全文
  • Elisabeth Hessmann,
  • Günter Schneider

摘要

Epigenetic therapies represent a novel and promising approach to treating a wide range of diseases, particularly cancer. By targeting and reversing the epigenetic changes, these therapies can precisely modulate gene expression to interfere with tumor growth and progression. Using EZH2 (enhancer of zeste homolog 2) inhibitors as a case study, we delve into recent advancements in the field of epigenetic therapy and discuss strategies to fully harness the potential of epigenetic therapeutics.